Oral cladribine delays time to conversion to clinically definite ms in patients with a first demyelinating event: Top line results from the phase III oracle ms study

Authors
Category Primary study
JournalNeurology
Year 2013
This article has no abstract
Epistemonikos ID: f0f36c13ba55b3d209a240d659ff926edd07939f
First added on: Feb 05, 2025